Clinical Trial Update: A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous Telisotuzumab Adizutecan with Bevacizumab versus standard Bevacizumab plus oral Trifluridine/Tipiracil in adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Lonsurf (trifluridine/tipiracil)
• Telisotuzumab Adizutecan (Telisotuzumab Adizutecan)

Snippet

Sponsor: AbbVie | Conditions: Colorectal Cancer | Phase 3 | Status: NOT_YET_RECRUITING